Cytogenetics and its prognostic value in myelodysplastic syndromes

被引：0
|
作者：
Verhoef, GEG
Boogaerts, MA
机构：
来源：
ACTA HAEMATOLOGICA | 1996年 / 95卷 / 02期
关键词：
myelodysplastic syndromes; chromosomes; prognosis; hemopoietic growth factors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this review we describe the cytogenetics of primary and secondary myelodysplastic syndromes, discuss their relationship with other hemopoietic malignancies, and also attempt to put the described chromosome abnormalities into a clinically more useful perspective by emphasizing the prognostic impact they carry. In addition, we discuss their use as clonal markers in determining the mode of action and efficiency of different therapeutic approaches.
引用
收藏
页码：95 / 101
页数：7
相关论文
共 50 条
  • [1] The cytogenetics of myelodysplastic syndromes
    Olney, HJ
    Le Beau, MM
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (03) : 479 - 495
  • [2] The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes
    Lorand-Metze, I.
    Califani, S. M. V.
    Ribeiro, E.
    Lima, C. S. P.
    Metze, K.
    LEUKEMIA RESEARCH, 2008, 32 (02) : 211 - 213
  • [3] Clinical relevance of cytogenetics in myelodysplastic syndromes
    Bernasconi, Paolo
    Boni, Marina
    Cavigliano, Paola Maria
    Calatroni, Silvia
    Giardini, Ilaria
    Rocca, Barbara
    Zappatore, Rita
    Dambruoso, Irene
    Caresana, Marilena
    ESTROGENS AND HUMAN DISEASES, 2006, 1089 : 395 - 410
  • [4] Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes
    Wimazal, F
    Sperr, WR
    Kundi, M
    Meidlinger, P
    Fonatsch, C
    Jordan, JH
    Thalhammer-Scherrer, R
    Schwarzinger, I
    Geissler, K
    Lechner, K
    Valent, P
    LEUKEMIA RESEARCH, 2001, 25 (04) : 287 - 294
  • [5] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes
    Duong, Vu H.
    Padron, Eric
    Al Ali, Najla H.
    Lancet, Jeffrey E.
    Hall, Jeff
    Kwok, Brian
    Zhang, Ling
    Epling-Burnette, Pearlie K.
    List, Alan F.
    Komrokji, Rami S.
    ANNALS OF HEMATOLOGY, 2018, 97 (02) : 247 - 254
  • [6] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes
    Vu H. Duong
    Eric Padron
    Najla H. Al Ali
    Jeffrey E. Lancet
    Jeff Hall
    Brian Kwok
    Ling Zhang
    Pearlie K. Epling-Burnette
    Alan F. List
    Rami S. Komrokji
    Annals of Hematology, 2018, 97 : 247 - 254
  • [7] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES
    SANZ, GF
    SANZ, MA
    LEUKEMIA RESEARCH, 1992, 16 (01) : 77 - 86
  • [8] Prognostic molecular markers in myelodysplastic syndromes
    Neukirchen, Judith
    Haas, Rainer
    Germing, Ulrich
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (05) : 563 - 575
  • [9] CORRELATIONS BETWEEN CYTOGENETICS AND MORPHOLOGY IN MYELODYSPLASTIC SYNDROMES
    VILA, L
    CHARRIN, C
    ARCHIMBAUD, E
    TREILLERITOUET, D
    FRAISSE, J
    FELMAN, P
    FIERE, D
    GERMAIN, D
    BLUT, 1990, 60 (04): : 223 - 227
  • [10] The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes
    Deliliers, GL
    Annaloro, C
    Soligo, D
    Oriani, A
    LEUKEMIA & LYMPHOMA, 1998, 28 (3-4) : 231 - +
12345